Challenges of IP chemotherapy for ovarian cancer.
Anselmo-Murphy
Anne M
AM
The Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002408:Catheters, Indwelling / Q000592:standards; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D006979:Hyperthermia, Induced; D007263:Infusions, Parenteral / Q000009:adverse effects / Q000379:methods*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000628:therapy
D000970:Antineoplastic Agents